MDNN: Pediatric HIV, Diabetes Websites, Hypertension Guidelines, and an FDA Drug Tablet


Stay updated on the biggest headlines with MDNN from November 17, 2017.

Hi, I’m Jenna Payesko, and this is MD Magazine News Network - it’s clinical news for connected physicians.

A new study has found that HIV affects brain development in pediatric patients, whether or not they are taking antiretroviral therapy. The study, led by researchers from the University of Cape Town in South Africa, found that even if children are not infected with HIV, those who are exposed experience changes in their brain’s white matter integrity. Researchers were sure to note that there is still overwhelming evidence indicating early ART treatment is beneficial for pediatric patients.

Diabetes-specific websites that promote physical activity in type 2 diabetes patients generally do not result in an increase in physical activity among visiting patients. Researchers have found that sites promoting physical activity may neglect to include input from health professionals or diabetes patients during development, leading to a null point in the site’s mission. There’s still hope, though. Lead author Dr. Jenni Connelly told MD Magazine that some interactive website components could help improve behavior in type 2 diabetes patients.

The American Heart Association and American College of Cardiology has released new guidelines for hypertension, marking the first update in nearly 15 years. The new guidelines lowered the threshold for Stage 1 hypertension to 130/80, and eliminated the prehypertension stage altogether. With the new definition in place, it is estimated that roughly half of Americans have Stage 1 hypertension.

The FDA has approved the first tablet to come equipped with a sensor that can digitally track whether or not patients have taken their medication. The aripiprazole tablets — which are approved for the treatment of schizophrenia, bipolar I disorder, and as an add-on for depression – will be equipped with tracking technology aimed at reducing medical waste and improve adherence to therapy. Current estimates suggest that 50% of patients with chronic conditions do not take their medication.

And now, please enjoy expert insights into psoriatic arthritis from Allan Gibofsky, MD.

For more clinical insights direct from the experts, visit

I’m Jenna Payesko for MDNN, thank for you watching.

Related Videos
Caroline Sisson, MMS, PA-C: Updates in Pulmonary Function Testing
Should We Reclassify Diabetes Subtypes?
Primary Care Roles in Alzheimer Diagnosis, with Theresa Sivers-Teixeira, MSPA, PA-C
Heart Failure Treatment Outcomes and Contraindications
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Depression Screening: Challenges and Solutions at the Primary Care Level
© 2024 MJH Life Sciences

All rights reserved.